Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

30 Jul 2015 14:11

RNS Number : 6078U
Skyepharma PLC
30 July 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Skyepharma PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s)  (if different from 3.):iv

Registered Holder:

 

BNY Norwich Union Nominees Limited 270,719*

 

Chase (GA Group) Nominees Limited 7,060,711*

 

Available on Request 130*

* denotes direct interest

Chase (GA Group) Nominees Limited 274,639

Chase Nominees Limited 217,282

 

Vidacos Nominees Limited 383,849

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

29 July 2015

6. Date on which issuer notified:

30 July 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

7% to 6% Change at Direct Interest Level

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares GBP1GB00B3BFNB64

 

 

 

8,336,174

 

 

 

8,336,174

8,207,330

7,331,560

875,770

6.99%

0.84%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,207,330

7.83%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:-

 

Aviva Investors Global Services Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

Friends Provident International Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited)

· Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited)

· Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited)

· Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited)

· Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited)

 

 

 

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

 

13. Additional information:

Aviva have disclosed: Figures are based on a total number of voting rights of 104,812,259 as per the Company's Completion of Capital Raising and Admission of New Shares of 29 April 2014.

 

14. Contact name:

C Carpenter

15. Contact telephone number:

020 7881 1173

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLXBLFXEDFBBBV
Date   Source Headline
1st Jun 20163:20 pmRNSForm 8.3 - Skypepharma PLC
1st Jun 201612:29 pmRNSForm 8.3 - Skyepharma PLC
1st Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
1st Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
1st Jun 201610:51 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
1st Jun 201610:09 amRNSForm 8.3 - Vectura Group plc
1st Jun 20169:30 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
31st May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
31st May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
31st May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
31st May 20161:24 pmRNSForm 8.3 - Vectura Group Plc
31st May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
31st May 201610:36 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
31st May 20169:37 amRNSForm 8.3 - Vectura Group plc
31st May 20168:55 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
31st May 20167:00 amRNSForm 8.3 - Skyepharma PLC
27th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
27th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
27th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
27th May 20161:58 pmRNSForm 8.3 - [Skyepharma plc]
27th May 20161:55 pmRNSForm 8.3 - Vectura Group Plc
27th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
27th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
27th May 201610:24 amRNSForm 8.3 - Vectura Group plc
27th May 201610:16 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
27th May 20169:49 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
26th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
26th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
26th May 20162:46 pmRNSForm 8.3 - Skyepharma
26th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
26th May 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
26th May 20169:04 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th May 20168:52 amRNSForm 8.3 - Vectura Group plc
25th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
25th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
25th May 20163:23 pmRNSForm 8.3 - Skyepharma Plc
25th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
25th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
25th May 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
25th May 20169:28 amRNSForm 8.3 - Vectura Group plc
25th May 20169:07 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
24th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
24th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
24th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
24th May 201610:55 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
24th May 20169:37 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 20169:33 amRNSForm 8.3 - Skyepharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.